Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases/Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases/Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases/Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Pati

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2021-09, Vol.326 (11), p.1067
Hauptverfasser:	Papamichail, Konstantinos, Dubinsky, Marla C, Cheifetz, Adam S, Serkland, Trond Trætteberg, Skrede, Silje, Berg, Jon Andsnes, Tilly, Olivier Le, Paintaud, Gilles, Ternant, David, Syversen, Silje Watterdal, Bolstad, Nils, Haavardsholm, Espen A
Format:	Artikel
Sprache:	eng
Schlagworte:	Inflammatory diseases Infliximab Monitoring Monoclonal antibodies Therapeutic drug monitoring Therapy Tumor necrosis factor-α
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!